Legend Biotech Corp (LEGN)
45.30
+0.88
(+1.98%)
USD |
NASDAQ |
Apr 26, 16:00
45.30
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Total Assets (Quarterly): 1.849B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.849B |
| September 30, 2023 | 1.839B |
| June 30, 2023 | 1.931B |
| March 31, 2023 | 1.209B |
| December 31, 2022 | 1.331B |
| June 30, 2022 | 1.023B |
| March 31, 2022 | 1.041B |
| December 31, 2021 | 1.119B |
| Date | Value |
|---|---|
| September 30, 2021 | 813.76M |
| June 30, 2021 | 875.12M |
| March 31, 2021 | 615.25M |
| December 31, 2020 | 722.09M |
| September 30, 2020 | 708.64M |
| June 30, 2020 | 772.86M |
| March 31, 2020 | 364.94M |
| December 31, 2019 | 287.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
287.72M
Minimum
Dec 2019
1.931B
Maximum
Jun 2023
1.031B
Average
948.94M
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 167.56B |
| Bristol-Myers Squibb Co | 95.16B |
| 2seventy bio Inc | 565.43M |
| Exelixis Inc | 2.942B |
| Alnylam Pharmaceuticals Inc | 3.830B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 597.24M |
| Shareholders Equity (Quarterly) | 1.251B |
| Debt to Equity Ratio | 0.2248 |
| Current Ratio | 6.921 |
| Net Debt Paydown Yield | -0.51% |